ViroGates offers free test kits to hospitals in Denmark to test potential COVID-19 patients
More and more patients are presenting with respiratory symptoms, that may indicate coronavirus infection, at hospitals Emergency Departments.
In order to help Emergency Departments at Danish hospitals make faster and better decisions regarding who to send home, and who to admit to the hospital for care, ViroGates has decided to offer free suPARnostic® test kits to the Danish hospitals.
Optimize your emergency room flow
suPARnostic® is a prognostic inflammatory biomarker that reflects the level of activation of the human immune system. A low suPAR level indicates a good prognosis and supports the decision to discharge the patient.
A high suPAR level indicates presence, progression and severity of disease, organ damage and risk of mortality, and supports further clinical attention.
This enables you to make your clinical decision based on prognostic evidence.
Read our latest news in our Press Room regarding our products, our company, suPAR abstracts and presentations, conferences and congresses where you can find us etc.
suPARnostic® Quick Triage will now be available for clinical decision making at seven hospitals in Region Zealand, Denmark. The analyses will initially be conducted at Næstved Hospital’s clinical immunology department. [...]
Due to the current state of affairs regarding the COVID-19 crisis, ViroGates has decided to make our suPARnostic® products available free of charge to the Emergency Departments in Denmark. By [...]
suPARnostic® is developed to measure the amount of suPAR protein (soluble urokinase Plasminogen Activator Receptor) in human blood.
It is the only CE-IVD certified product range applied for clinical determination of suPAR in human plasma and serum.
The suPARnostic® brand consists of the following 3 products:
For Automated Systems
Quick Triage Test
A Point of Care Solution
For Clinical and Research Use